A novel apoptosis pathway activated by the carboxyl terminus of p21
Chen Dong1, Qing Li, Shu-Chen Lyu
1Division of Immunology and Transplantation Biology, Department of Pediatrics, CCSR 2105, 300 Pasteur Dr, Stanford University, Stanford, CA 94305-5164, USA.
Abstract:
Delivery of biologically active peptides into cells may help elucidate intracellular signal transduction pathways, identify additional in vivo functions, and develop new therapeutics. Although p21 was first identified as a major regulator of cell cycle progression, it is now clear that p21 subserves multiple functions. The amino terminus of p21 interacts with cyclins and cyclin-dependent kinases, while the carboxyl terminus interacts with proliferating cell nuclear antigen (PCNA), growth arrest and DNA damage-inducible gene 45 (GADD45), calmodulin, SET, and CCAAT/enhancer binding protein-alpha (C/EBP-alpha). A chimeric peptide, p21-IRS, consisting of the carboxyl terminal domain of p21 conjugated to a pentapeptide (RYIRS) rapidly enters lymphoid cells and activates apoptosis. In the present study, we investigate the molecular events involved in p21-activated apoptosis. Comparison of p21-IRS with other known proapoptotic agents demonstrates that p21-IRS activates a novel apoptotic pathway: mitochondria are central to the process, but caspases and a decrease in Deltapsi(m) are not involved. Targeting the p21 peptide to specific cell populations may allow development of novel therapies to eliminate aberrant cells in human diseases.
Insights
A novel peptide, p21-IRS, induces apoptosis in lymphoid cells via a unique mitochondrial pathway. This discovery offers potential for new cancer therapies targeting aberrant cells.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The protein p21 regulates cell cycle progression and has diverse cellular functions.
- p21 interacts with various proteins including cyclins, cyclin-dependent kinases, and proliferating cell nuclear antigen (PCNA).
- Delivery of active peptides into cells is crucial for studying intracellular processes and developing therapeutics.
Purpose of the Study:
- To investigate the molecular mechanisms of apoptosis induced by the chimeric peptide p21-IRS.
- To determine if p21-IRS activates a known or novel apoptotic pathway.
- To explore the therapeutic potential of p21-IRS for eliminating aberrant cells.
Main Methods:
- Synthesis of a chimeric peptide, p21-IRS, comprising the p21 carboxyl terminus and a cell-penetrating pentapeptide (RYIRS).
- Treatment of lymphoid cells with p21-IRS and comparison with other proapoptotic agents.
- Analysis of molecular events during p21-IRS-induced apoptosis, focusing on mitochondrial involvement, caspases, and mitochondrial membrane potential (Deltapsi(m)).
Main Results:
- The p21-IRS peptide rapidly enters lymphoid cells and effectively activates apoptosis.
- p21-IRS triggers a novel apoptotic pathway distinct from those activated by conventional proapoptotic agents.
- Mitochondria play a central role in p21-IRS-induced apoptosis, but caspases and a decrease in Deltapsi(m) are not involved.
Conclusions:
- p21-IRS activates a unique, caspase- and Deltapsi(m)-independent apoptotic pathway centered on mitochondria.
- Targeting specific cell populations with p21-IRS holds promise for developing innovative therapies against human diseases characterized by aberrant cell proliferation.
- Further research into this novel pathway could reveal new therapeutic strategies.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Caspases


